Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Portable, parallel 9-wavelength near-infrared spectral tomography (NIRST) system for efficient characterization of breast cancer within the clinical oncology infusion suite.

Zhao Y, Pogue BW, Haider SJ, Gui J, diFlorio-Alexander RM, Paulsen KD, Jiang S.

Biomed Opt Express. 2016 May 16;7(6):2186-201. doi: 10.1364/BOE.7.002186. eCollection 2016 Jun 1.

2.

Noninvasive Surface Imaging of Breast Cancer in Humans using a Hand-held Optical Imager.

Erickson-Bhatt SJ, Roman M, Gonzalez J, Nunez A, Kiszonas R, Lopez-Penalver C, Godavarty A.

Biomed Phys Eng Express. 2015 Dec;1(4). pii: 045001. Epub 2015 Oct 23.

PMID:
27366327
3.

Optical mammography: bilateral breast symmetry in hemoglobin saturation maps.

Anderson PG, Sassaroli A, Kainerstorfer JM, Krishnamurthy N, Kalli S, Makim SS, Graham RA, Fantini S.

J Biomed Opt. 2016 Oct;21(10):101403. doi: 10.1117/1.JBO.21.10.101403.

PMID:
26849841
4.

Experimental validation of a high-resolution diffuse optical imaging modality: photomagnetic imaging.

Nouizi F, Luk A, Thayer D, Lin Y, Ha S, Gulsen G.

J Biomed Opt. 2016 Jan;21(1):16009. doi: 10.1117/1.JBO.21.1.016009. No abstract available.

PMID:
26790644
5.

Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures.

Chung SH, Feldman MD, Martinez D, Kim H, Putt ME, Busch DR, Tchou J, Czerniecki BJ, Schnall MD, Rosen MA, DeMichele A, Yodh AG, Choe R.

Breast Cancer Res. 2015 May 27;17:72. doi: 10.1186/s13058-015-0578-z.

6.

Broadband optical mammography: chromophore concentration and hemoglobin saturation contrast in breast cancer.

Anderson PG, Kainerstorfer JM, Sassaroli A, Krishnamurthy N, Homer MJ, Graham RA, Fantini S.

PLoS One. 2015 Mar 17;10(3):e0117322. doi: 10.1371/journal.pone.0117322. eCollection 2015.

7.

Pathologic response prediction to neoadjuvant chemotherapy utilizing pretreatment near-infrared imaging parameters and tumor pathologic criteria.

Zhu Q, Wang L, Tannenbaum S, Ricci A Jr, DeFusco P, Hegde P.

Breast Cancer Res. 2014 Oct 28;16(5):456. doi: 10.1186/s13058-014-0456-0.

8.

Optical wavelength selection for improved spectroscopic photoacoustic imaging.

Luke GP, Nam SY, Emelianov SY.

Photoacoustics. 2013 Aug 28;1(2):36-42. doi: 10.1016/j.pacs.2013.08.001. eCollection 2013 May.

9.

Optically measured microvascular blood flow contrast of malignant breast tumors.

Choe R, Putt ME, Carlile PM, Durduran T, Giammarco JM, Busch DR, Jung KW, Czerniecki BJ, Tchou J, Feldman MD, Mies C, Rosen MA, Schnall MD, DeMichele A, Yodh AG.

PLoS One. 2014 Jun 26;9(6):e99683. doi: 10.1371/journal.pone.0099683. eCollection 2014.

10.

Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture.

Sadeghi-Naini A, Sannachi L, Pritchard K, Trudeau M, Gandhi S, Wright FC, Zubovits J, Yaffe MJ, Kolios MC, Czarnota GJ.

Oncotarget. 2014 Jun 15;5(11):3497-511.

11.

Imaging tumor hypoxia to advance radiation oncology.

Lee CT, Boss MK, Dewhirst MW.

Antioxid Redox Signal. 2014 Jul 10;21(2):313-37. doi: 10.1089/ars.2013.5759. Epub 2014 Mar 24. Review.

12.

Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics.

Busch DR, Choe R, Durduran T, Yodh AG.

PET Clin. 2013 Jul;8(3). doi: 10.1016/j.cpet.2013.04.004.

13.

Depth discrimination in diffuse optical transmission imaging by planar scanning off-axis fibers: initial applications to optical mammography.

Kainerstorfer JM, Yu Y, Weliwitigoda G, Anderson PG, Sassaroli A, Fantini S.

PLoS One. 2013;8(3):e58510. doi: 10.1371/journal.pone.0058510. Epub 2013 Mar 14.

14.

Evaluation of neoadjuvant chemotherapy response in women with locally advanced breast cancer using ultrasound elastography.

Falou O, Sadeghi-Naini A, Prematilake S, Sofroni E, Papanicolau N, Iradji S, Jahedmotlagh Z, Lemon-Wong S, Pignol JP, Rakovitch E, Zubovits J, Spayne J, Dent R, Trudeau M, Boileau JF, Wright FC, Yaffe MJ, Czarnota GJ.

Transl Oncol. 2013 Feb;6(1):17-24. Epub 2013 Feb 1.

15.

Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapy.

Busch DR, Choe R, Rosen MA, Guo W, Durduran T, Feldman MD, Mies C, Czerniecki BJ, Tchou J, Demichele A, Schnall MD, Yodh AG.

Biomed Opt Express. 2013 Jan 1;4(1):105-21. doi: 10.1364/BOE.4.000105. Epub 2012 Dec 14.

16.

Breast cancer: assessing response to neoadjuvant chemotherapy by using US-guided near-infrared tomography.

Zhu Q, DeFusco PA, Ricci A Jr, Cronin EB, Hegde PU, Kane M, Tavakoli B, Xu Y, Hart J, Tannenbaum SH.

Radiology. 2013 Feb;266(2):433-42. doi: 10.1148/radiol.12112415. Epub 2012 Dec 21.

17.

Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.

Choe R, Durduran T.

IEEE J Sel Top Quantum Electron. 2012 Jul;18(4):1367-1386. Epub 2011 Dec 2.

18.

Diffuse optical spectroscopy evaluation of treatment response in women with locally advanced breast cancer receiving neoadjuvant chemotherapy.

Falou O, Soliman H, Sadeghi-Naini A, Iradji S, Lemon-Wong S, Zubovits J, Spayne J, Dent R, Trudeau M, Boileau JF, Wright FC, Yaffe MJ, Czarnota GJ.

Transl Oncol. 2012 Aug;5(4):238-46. Epub 2012 Aug 1.

19.

Diffuse optical imaging using spatially and temporally modulated light.

O'Sullivan TD, Cerussi AE, Cuccia DJ, Tromberg BJ.

J Biomed Opt. 2012 Jul;17(7):071311. doi: 10.1117/1.JBO.17.7.071311. Review.

20.

Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRI.

Chung SH, Yu H, Su MY, Cerussi AE, Tromberg BJ.

J Biomed Opt. 2012 Jul;17(7):071304. doi: 10.1117/1.JBO.17.7.071304.

Items per page

Supplemental Content

Write to the Help Desk